Product Information

GABAPENTIN ER 600 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.9984 per EA under NDC 50228052490. Its NADAC has been published 25 times since Jan 7, 2026.

The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN ER 600 MG TABLET

gabapentin
$0.9984per EA
High Outlier

Strength

600 mg/1

NDC

50228052490

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA218491

On Market Since

9/20/2025

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN ER 600 MG TABLET has been published 25 times since Jan 7, 2026, and over the history we have for it it has declined 34.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9984 per EA
All-time high$1.5217 (Jan 14, 2026)
All-time low$0.9984 (Jun 17, 2026)
52-week high$1.5217
52-week low$0.9984
Median price$1.2732
Average price$1.2582
Largest weekly change-11.0% (Jun 17, 2026)
Weeks tracked25
Tracking sinceJan 7, 2026

Price History

1W

0.0%

1M

-11.0%

3M

-21.8%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-34.4%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN ER 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN ER 600 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.9984 per EA (NDC 50228052490), effective Jun 24, 2026.

How has the price of GABAPENTIN ER 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN ER 600 MG TABLET has declined 34.4%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.

What are the highest and lowest recorded NADAC prices for GABAPENTIN ER 600 MG TABLET?

Since Jan 7, 2026, the NADAC for GABAPENTIN ER 600 MG TABLET has ranged from a low of $0.9984 (Jun 17, 2026) to a high of $1.5217 (Jan 14, 2026), with a median of $1.2732 per EA.

Are there cheaper alternatives to GABAPENTIN ER 600 MG TABLET?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 600 MG TABLET, is $0.0668 per EA — about 93% below GABAPENTIN ER 600 MG TABLET.

Who manufactures GABAPENTIN ER 600 MG TABLET?

GABAPENTIN ER 600 MG TABLET (NDC 50228052490) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.